Gender differences in tuberculosis  by Thorson, A.E.
16th ICID Abstracts / International Journal of Infectious Diseases 21S (2014) 1–460 65
Type: Invited Presentation
Final Abstract Number: 31.001
Session: Gender Differences in Infectious Diseases
Date: Saturday, April 5, 2014
Time: 10:15-12:15
Room: Room 1.60
Sex differences in immune responses to
vaccines
F. Noho-Konteh1, J. Adetifa1, M. Cox1, T. Forster2,
A. Drammeh1, J. Njie-Jobe1, D. Jeffries1, M.
Plebanski3, P. Ghazal2, P. Dickinson2, H.
Whittle1, S. Rowland-Jones4, J. Sutherland1, K.
Flanagan5,∗
1 MRC Laboratories, Banjul, Gambia
2 University of Edinburgh Medical School, Edinburgh,
United Kingdom
3 Monash University, Melbourne, Australia
4 University of Oxford, Oxford, United Kingdom
5 Monash University, Melbourne, TAS, Australia
Sex differences in susceptibility to infections, and their clinical
course and outcome, have been well described in the liter-
ature. Thus adult females generally mount more pronounced
pro-inﬂammatory innate and adaptive immune responses to viral
and bacterial infections than males, and generally males have
poorer outcomes in bacterial septic shock. Despite this, few stud-
ies consider the effect of sex when analysing responses to vaccines.
Females have been shown tomount stronger humoral responses to
vaccines compared to males and have higher rates of adverse reac-
tions. Additionally, adult females have been shown to up-regulate
more innate immune response genes following yellow fever vacci-
nation than males. The paucity of literature, particularly in regards
to infant immunity, prompted us to examine the inﬂuence of sex
on vaccine responses in more detail. We conducted a series of
immunological vaccine studies in infants living in The Gambia,
West Africa. We analysed for sex differences in the immunolog-
ical proﬁles following administration of measles vaccine (MV) or
diphtheria, tetanus,whole cells pertussis combinedvaccine (DTwP)
to nine month old infants. Assays included whole human trans-
criptional proﬁle analysis, vaccine antibodies, in vitro cytokine
release in response to innate stimuli or cognate antigens, as well
as intracellular cytokine staining to enumerate polyfunctional T
cells. There were clear sex differences in post-vaccine immunity
formost of the parameters tested. Generally,male infants hadmore
pro-inﬂammatory innate and adaptive immune response proﬁles
compared to females of the same age. The sexes differed in their
transcriptional proﬁles following vaccination, with distinct sets of
genes being differentially expressed. By contrast, vaccine induced
antibody responses to MV and DTwP were equivalent in male and
female infants. The observation of sex differences in the immune
responses elicited by vaccines has a number of important implica-
tions. It suggests that sex should be taken into account in vaccine
studies; particularly for novel vaccines and in vaccine safety tri-
als. Failing to do so may miss important data. The mechanisms are
not yet known, but differences in sex hormone levels and expres-
sion of X-linked immune responses and microRNAs genes may be
involved.
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Sex discrepancies in vector-borne infectious
diseases
P. Schlagenhauf
University of Zürich, Zurich, Switzerland
Infectiousdiseasesoccurdisproportionately inmenandwomen.
Furthermore, the severity and outcome of infections are often sex-
related. What are the underlying factors for these discrepancies?
Some studies have pinpointed a marked sex difference in immune
response. Females typically develop stronger innate, cell-mediated
and humoral immune responses with ﬂuctuations according to
hormonal levels that vary naturally during the menstrual cycle,
pregnancy, menopause or with the use of hormones as contra-
ceptives or hormone replacement therapy. Male sex hormones
have been implicated in immunoregulation. Testosterone causes
a decline in certain immune responses and young men are often at
greater risk of severe infections compared to women or older men.
The hormonal household and the skin chemistry also inﬂuence the
attractiveness ofmen andwomen tomosquitoes and other vectors.
On the other side of the equation, gender factors play a role
in susceptibility to vector-borne infections. Behavioural, occupa-
tional and cultural differences lead to gender differences in vector
exposure, use of personal protection measures and health seeking
practices.
This presentation highlights sex discrepancies in infections
transmitted by mosquitoes and ticks and places this evidence
in context in terms of physiological factors and gender-speciﬁc
behaviour.
http://dx.doi.org/10.1016/j.ijid.2014.03.557
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Gender differences in tuberculosis
A.E. Thorson
Karolinska Institute, Solna, Sweden
Tuberculosis shows marked differences between males and
females in terms of detection and notiﬁcation, progression to dis-
ease after infection and disease outcome, as well as the social
consequences of the disease. Both biological sex and socially
constructed gender differences are important determinants of
tuberculosis and they interact to produce differences in risks
and vulnerability. Furthermore, these factors interact with other
social determinants to effect health outcomes. The social struc-
ture of many societies in low-income countries today relies on
women having a double or triple workload, including household,
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agricultural and/or waged work. As women are also the primary
carers in the family, the impact of tuberculosis is severe for indi-
vidual families as for society in general.
Evidence of gender disparities from studies in collaboration
betweenKarolinska Institutet andHanoiMedical University aswell
as fromthe literature include that TBdisease in somecontexts could
inﬂuence possibilities to marry, to stay married and even so via
proxy, since in particular women in a family with TB disease would
face barriers to marriage. Married women with TB may be at risk
of divorce, of their husband taking a second wife, or of being sent
to their natal homes. In Pakistan, marriage prospects as perceived
by parents inﬂuence treatment taking among unmarried children.
Conclusions: Gender dynamics are thus key factors affecting the
risk of a person becoming infected and developing tuberculosis
as well as his or her access to health information, health-seeking
behaviour and treatment outcome. In addition, gender norms and
gender inequality inﬂuence coping capacities and the social conse-
quences of having tuberculosis.
Future research needs include: Population-based studies in mul-
tiple settings together with sentinel surveillance activities are
recommended togetunbiaseddataonTB incidenceandprevalence.
Semi-active case-identiﬁcation in target populations, acknowledg-
ing the devastating effects of the interaction between gender and
HIV, eg. TB screening linked to PMTCTMore basic science initiatives
to investigate sex differences in immune response to infection and
determinants of disease development and the link to sex speciﬁc
hormone levels
http://dx.doi.org/10.1016/j.ijid.2014.03.558
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Sex differences in antiretroviral therapy efﬁcacy
and toxicity
J. Currier
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The development of effective combination antiretroviral ther-
apy (ART) has transformed the management of HIV infection
over the past twenty years, yet many challenges remain. Globally
women comprise half of all people living with HIV, yet women
have been underrepresented in most clinical trials evaluating the
efﬁcacy and safety of ART. More recently several groups of inves-
tigators have designed and analyzed clinical trials with a goal of
evaluating sex difference in ART. These studies have suggested
differential rates of toxicity in women and men and some impor-
tant differences in response rates to standard treatments. This
presentation will review recent ﬁndings on sex differences in
the pharmacokinetics of protease inhibitors and non-nucleoside
reverse transcriptase inhibitors and highlight sex differences and
efﬁcacy from recent clinical trials. Finally research priorities in the
area of sex differences in HIV therapy will be suggested.
http://dx.doi.org/10.1016/j.ijid.2014.03.559
Type: Invited Presentation
Final Abstract Number: 32.001
Session: Rickettsitosis in Africa
Date: Saturday, April 5, 2014
Time: 10:15-12:15
Room: Room 2.40
Rickettsial diseases in Eastern Africa
A. Richards
Naval Medical Research Center, MD 20910-7500
USA, Silver Spring, MD, USA
Rickettsial diseases have been described in Eastern Africa
for over 50 years. These include: epidemic typhus (Rickettsia
prowazekii), murine typhus, (Rickettsia typhi) and Mediterranean
spotted fever also known as Kenyan tick typhus (Rickettsia conorii
subsp. conorii). Contemporary reports describe these samediseases
in addition to new rickettsiae and rickettsial diseases utilizing sero-
logical and molecular techniques. Some of the new agents and
diseases include: Rickettsia felis (ﬂea-borne spotted fever), Rick-
ettsia felis-like organisms (e.g. Candidatus Rickettsia asemboensis),
Rickettsia africae (African tick-bite fever), Rickettsia africae vari-
ants (e.g. Rickettsia sp. AVR4), Rickettsia aeschlimanni (an unnamed
tick-borne rickettsiosis), Rickettsia sibirica subsp. mongolitimonae
(lymphangitis-associated rickettsiosis), Rickettsia conorii subsp.
israelensis (Israeli spotted fever) and Candidatus Rickettsia kulagini.
These reports indicate that individuals residing in and thosevisiting
Eastern Africa are at risk of various rickettsial diseases. Unfortu-
nately, the dearth of comprehensive studies of the prevalence and
distribution of these rickettsiae or the incidence of the particular
rickettsioses hinder development of proper mitigation strategies.
http://dx.doi.org/10.1016/j.ijid.2014.03.560
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Rickettsioses in Africa: A paradigm of new or
emerging infectious diseases
D. Raoult
Faculté de la Mediterranée, Marseilles, France
Rickettsioses were considered 20 years ago as being rare dis-
eases with one species of Rickettsia transmitted by ticks, per
continent. Modern tools have been disrupting the perception of
the world of rickettsioses. The ﬁrst works were performed directly
on biting arthropods (ticks, ﬂeas, mites) that helped to identify a
number of microorganisms putatively involved in human diseases.
This difﬁculty to use classical tools for diagnosis in patients (such
as culture), prevented for a long time the identiﬁcation of human
cases. The development of molecular tools based on skin (biopsies
and swabs), and blood shows the huge frequency of rickettsioses.
In rural Asia, rickettsioses (scrub typhus and murine typhus) are
among the most frequent cause of unexplained prolonged fever.
In western and eastern Africa, rickettsioses (mainly R. felis) are the
